Guillain-Barré Syndrome with Slow Progressive Onset and Persistent Elevation of Spinal Fluid Protein
Authors: ROBERT C. HINMAN
Journal: Annals of Internal Medicine (1967)

Article1 November 1967Guillain-Barré Syndrome with Slow Progressive Onset and Persistent Elevation of Spinal Fluid ProteinROBERT C. HINMAN, M.D., KENNETH R. MAGEE, M.D., F.A.C.P.ROBERT C. HINMAN, M.D., KENNETH R. MAGEE, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-67-5-1007 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptClassification of the Guillain-Barré syndrome has been the subject of much discussion and review (1-11). The diversity of the clinical manifestations has led some clinicians to establish criteria that would more precisely delimit the syndrome (1). Others take issue with this restrictive tendency, believing that it excludes certain clinical manifestations such as profound sensory loss, relapses, and ataxia that should be considered part of the syndrome (2-5, 12). This attempt at restrictive classification of the syndrome would be securely based if the etiologic mechanism(s) were understood. Despite the widely accepted parainfectious etiologic component, it is rarely possible to establish a...References1. OSLERSIDELL LDAD: The Guillain-Barré syndrome; the need for exact diagnostic criteria. New Eng. J. Med. 262: 964, 1960. CrossrefMedlineGoogle Scholar2. BROWNBAKER JRAB: The diagnosis of Guillain-Barré's disease. Amer. J. Med. 2: 45, 1947. CrossrefMedlineGoogle Scholar3. BOSHESSHERMAN BIC: Variability of the course of the Guillain-Barré syndrome. Neurology (Minneap.) 3: 789, 1953. CrossrefMedlineGoogle Scholar4. REISMAN M: Guillain-Barré syndrome (correspondence in response to (2)). New Eng. J. Med. 263: 48, 1960. CrossrefGoogle Scholar5. Annotations: Diagnosis of Guillain-Barré syndrome. Lancet 2: 84, 1960. Google Scholar6. POSERFOWLER CMCW: The nosologic situation of the Landry-Guillain-Barré syndrome. Acta Neurol. Scand. 39: 187, 1963. CrossrefMedlineGoogle Scholar7. LENEMAN F: The Guillain-Barré syndrome. Definition, etiology, and review of 1,100 cases. Arch. Intern. Med. (Chicago) 118: 139, 1966. CrossrefMedlineGoogle Scholar8. HAYMAKERKERNOHAN WJW: The Landry-Guillain-Barré syndrome: a clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine (Balt.) 28: 59, 1949. CrossrefMedlineGoogle Scholar9. MARSHALL J: The Landry-Guillain-Barré syndrome. Brain 86: 55, 1963. CrossrefGoogle Scholar10. WIEDERHOLTMULDERLAMBERT WCDWEH: The Landry-Guillain-Barré-Strohl syndrome or polyradiculoneuropathy: historical review, report on 97 patients, and present concepts. Mayo Clin. Proc. 39: 427, 1964. MedlineGoogle Scholar11. MCFARLANDHELLER HRGL: Guillain-Barré disease complex. A statement of diagnostic criteria and analysis of 100 cases. Arch. Neurol. (Chicago) 14: 196, 1966. CrossrefMedlineGoogle Scholar12. RICHTER RB: The ataxic form of polyradiculoneuritis (Landry-Guillain-Barré syndrome). Clinical and pathologic observations. J. Neuropath. Exp. Neurol. 21: 171, 1962. CrossrefMedlineGoogle Scholar13. GUILLAIN G: Radiculoneuritis with acellular hyperalbuminosis of the cerebrospinal fluid. Arch. Neurol. Psychiat. (Chicago) 36: 975, 1936. CrossrefGoogle Scholar14. MCINTYRE HD: Infective neuronitis. Ohio Med. J. 33: 875, 1937. Google Scholar15. DEJONG RN: The Guillain-Barré syndrome: polyradiculoneuritis with albumino-cytologic dissociation. Arch. Neurol. Psychiat. (Chicago) 44: 1044, 1940. CrossrefGoogle Scholar16. CROZIERAINLEY REAB: The Guillain-Barré syndrome. New Eng. J. Med. 252: 83, 1955. CrossrefMedlineGoogle Scholar17. HELLERDEJONG GLRN: Treatment of the Guillain-Barré syndrome. Use of corticotropin and glucocorticoids. Arch. Neurol. (Chicago) 8: 179, 1963. CrossrefMedlineGoogle Scholar18. FELDMAN S: Clinical observations on the value of adrenocortical therapy in the Guillain-Barré syndrome. Confin. Neurol. 26: 76, 1965. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ROBERT C. HINMAN, M.D.; KENNETH R. MAGEE, M.D., F.A.C.P.Affiliations: Ann Arbor, MichiganFrom the Department of Neurology, University of Michigan Medical Center, Ann Arbor, Mich.Requests for reprints should be addressed to Kenneth R. Magee, M.D., Department of Neurology, University of Michigan Medical Center, Ann Arbor, Mich. 48104. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byChronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and ManagementGuillain-Barré syndromes and chronic inflammatory demyelinating polyradiculoneuropathyCIDP - the relevance of recent advances in Schwann cell/axonal neurobiologyA Man with Progressive Weakness and FasciculationsChronic Inflammatory Demyelinating PolyradiculoneuropathyCorticosteroid use in the treatment of neuromuscular disorders: Empirical and evidence-based dataChronic Idiopathic Demyelinating PolyradiculoneuropathyThe idiopathic polyradiculoneuropathies: a historical guide to an understanding of the clinical syndromesChronic recurrent Guillain-Barré syndrome: report of 3 casesPeriphere NeuropathienLate onset of Guillain-Barré syndromePrednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentChronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatmentIsoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathyProgressive Polyradiculoneuropathy: Treatment with AzathioprineA case of chronic demyelinating polyneuropathy resembling the Guillain-Barré syndromeChronic relapsing polyneuritisThe Guillain-Barré Syndrome in Intensive CareEarly predictors of incomplete recovery in children with Guillain-Barré polyneuritisSTEROIDS AND GUILLAIN-BARRÉSYNDROMENATURAL ŒSTROGENS AND ANTITHROMBIN-III LEVELSAcute Glomerulonephritis in the Guillain-Barré-Strohl Syndrome Report of Nine CasesBERNARDO RODRÍGUEZ-ITURBE, M.D., RAFAEL GARCÍA, M.D., LÍRIMO RUBIO, M.D., JOSÉ ZABALA, M.D., GUILLERMO MOROS, M.D., ROLANDO TORRES, M.D.Diagnostic criteria for the Guillain-Barré syndromeRelapsing corticosteroid-dependent polyneuritisRemarkable recovery of a steroid-responsive recurrent polyneuropathy.Muscle Percussion and Neostigmine Test in the Clinical Evaluation of Neuromuscular DisordersRECOVERY IN LANDRY-GUILLAIN-BARRÉSYNDROME AFTER PROLONGED RESPIRATORY SUPPORT 1 November 1967Volume 67, Issue 5Page: 1007-1012KeywordsAtaxiaGuillain-Barre syndromeNeurologyProteins ePublished: 1 December 2008 Issue Published: 1 November 1967 PDF downloadLoading ...